Regulation of Autophagy and Cell Survival
AssigneeThe Trustees of the University of Pennsylvania
InventorsCraig B. Thompson, Julian Lum, Daniel Bauer
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Trustees of the University of Pennsylvania
InventorsCraig B. Thompson, Julian Lum, Daniel Bauer
Estimating the term…
Methods of treating an individual who has been identified as having glycolysis dependent cancer are disclosed. The methods comprise the step of: administering to such an individual a combination of an anti-cancer composition that renders the cancer incapable of glycolysis and an autophagy inhibitor. Pharmaceutical compositions and kits comprising that renders the cancer incapable of glycolysis and an autophagy inhibit are also disclosed. Methods of treating an individual who has a disease characterized b cell degeneration and cell death due to autophagy are disclosed. The methods comprise administering to the individual a permeable form of a metabolic substrate that can be oxidized in the tricarboxylic acid cycle to produce NADH. Methods for identifying an autophagy inhibitor comprising performing a test assay using an apopto sis-resistant cell are disclosed.
A method of treating an individual who has been identified as having a glycolysis dependent cancer comprising the step of:
A pharmaceutical composition or kit comprising one or more first anti-cancer compositions and one or more second anti-cancer compositions, wherein said first anticancer composition is a compound that converts glycolysis dependent cancer to cells incapable of glycolysis, and said second anti-cancer composition is an autophagy inhibitor.
A method of treating an individual who has a disease characterized by cell degeneration and death due to autophagy comprising the step of:
A method for identifying an autophagy inhibitor comprising performing a test assay comprising:
A method for identifying an autophagy inhibitor comprising performing a test assay comprising:
Dependencies are inferred from the claim text.